Novelty in Biomedicine

Vol. 7 No. 2 (2019)

The Study on Possible Gene Therapy on Diabetics Type I Using Insulin Gene under Control of Heat Shock Promoter in Laboratory Animals

Novelty in Biomedicine, Vol. 7 No. 2 (2019), 17 March 2019 , Page 45-48
https://doi.org/10.22037/nbm.v7i2.21934

Abstract

Background: Gene therapy is one of the treatment method for diabetes mellitus. An insulin gene, under control of heat shock inducer promoter was used in the study.

Materials and Methods: Six mice used in this study. Streptozotocin (STZ) induced diabetes mellitus in BALB/C mice and rats. Recombinant plasmid was injected to each animal. Animal’s blood sugar (BS) was measured. Warming was done at injection site with a hair dryer to induced gene expression.

Results: Immediately after warming blood sugar was increased in mouse 1 and decreased after one hour. However, blood sugar increased again in mice 2 and 4. Blood sugar increased for two hours after warming in mouse 3. Blood sugar increased to 150 mg/dl after STZ injection and immediately after warming reached to 160 mg/dl, after one hour BS dropped to 116 mg/dl and on the second hour was 126 mg/dl, in mouse 5 BS had an increasing trend, BS in mouse 6 had a similar pattern to mouse 2.

Conclusion: With fixing the defects of the project will be used in gene therapy in future.

Keywords:
  • Diabetes
  • Gene therapy
  • Streptozotocin

How to Cite

Ramezani, K., Gheflat, S., Jajarmi, V., Bandehpour, M., & Kazemi, B. (2019). The Study on Possible Gene Therapy on Diabetics Type I Using Insulin Gene under Control of Heat Shock Promoter in Laboratory Animals. Novelty in Biomedicine, 7(2), 45–48. https://doi.org/10.22037/nbm.v7i2.21934

References

Global report on diabetes. World Health Organization, Geneva, 2016 availabe at http://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=8B0019327E5309C002D09E9FEFAF7AE0?sequence=1

American Diabetes Association. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):55-64.

van Dellen D, Summers A, Trevelyan S, Tavakoli A, Augustine T, Pararajasingam R. Incidence and Histologic Features of Transplant Graft Pancreatitis: A Single Center Experience. Exp Clin Transplant. 2015;13(5):449-52.

Basta G, Montanucci P, Calafiore R. Islet transplantation versus stem cells for the cell therapy of type 1 diabetes mellitus. Minerva Endocrinol. 2015;40(4):267-82.

He CX1, Shi D, Wu WJ, Ding YF, Feng DM, Lu B, et al. Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration. World J Gastroenterol. 2004;10(4):567-72.

Thulé PM, Liu JM. Regulated hepatic insulin gene therapy of STZ-diabetic rats, Gene Ther. 2000;7:1744–52.

Chen R, Meseck ML, Woo SL. Auto-regulated Hepatic Insulin Gene Expression in Type 1 Diabetic Rats, Mol Ther. 2001;3(4):584–90.

Lee HC, Kim KS, Shin HC. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue, Nature. 2000;408:483-8.

Jajarmi V, Bandehpour M, Kazemi B. Regulation of insulin biosynthesis in non-beta cells by a heat shock promoter. J Biosci Bioeng. 2013;116 (2):147e151.

  • Abstract Viewed: 356 times
  • PDF Downloaded: 292 times

Download Statastics

Developed By

Open Journal Systems

Information